Fig. 1From: Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patientsPatients with solid tumors present with different levels of [68Ga]Pentixafor uptake in spleen. A Representative image of a 68-year-old female patient presenting with hepatocellular carcinoma and low spleen CXCR4 expression as measured by [68Ga]Pentixafor uptake. B Representative image of a 68-year-old male patient presenting with a neuroendocrine tumor and high spleen CXCR4 expression as measured by [68Ga]Pentixafor uptakeBack to article page